Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Near the Top of Equities by Percentage Gain on 9/13
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is one of today’s top gainers. The company’s shares are currently up 40.31% on the day to $21.45.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, and leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction.
So far today, approximately 11.92M shares of Rocket Pharmaceuticals, Inc. have been exchanged, as compared to an average 30-day volume of 448.46k shares.
Rocket Pharmaceuticals, Inc. share prices have moved between a 52-week high of $24.53 and a 52-week low of $11.78. The stock has moved 1.58% over the past week.
To learn more about Rocket Pharmaceuticals, Inc., visit the company’s website at https://rocketpharma.com.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com